CVS Health Corp (NYSE: CVS) has a price-to-earnings ratio that is above its average at 19.01x. The stock has a 36-month beta value of 0.57. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 7 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for CVS is 1.26B, and at present, short sellers hold a 1.45% of that float. On April 14, 2025, the average trading volume of CVS was 11.23M shares.
CVS) stock’s latest price update
CVS Health Corp (NYSE: CVS)’s stock price has soared by 0.78 in relation to previous closing price of 68.97. Nevertheless, the company has seen a gain of 9.19% in its stock price over the last five trading days. fool.com reported 2025-04-11 that Major stock market indexes are down significantly this year, with many of the most valuable companies in the world leading the descent. However, some companies are performing well.
CVS’s Market Performance
CVS Health Corp (CVS) has experienced a 9.19% rise in stock performance for the past week, with a 5.72% rise in the past month, and a 44.78% rise in the past quarter. The volatility ratio for the week is 5.62%, and the volatility levels for the past 30 days are at 3.27% for CVS.. The simple moving average for the past 20 days is 3.06% for CVS’s stock, with a 18.82% simple moving average for the past 200 days.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Leerink Partners repeating the rating for CVS by listing it as a “Outperform.” The predicted price for CVS in the upcoming period, according to Leerink Partners is $75 based on the research report published on February 13, 2025 of the current year 2025.
CVS Trading at 7.91% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.00% of loss for the given period.
Volatility was left at 3.27%, however, over the last 30 days, the volatility rate increased by 5.62%, as shares surge +5.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.33% upper at present.
During the last 5 trading sessions, CVS rose by +9.19%, which changed the moving average for the period of 200-days by +15.01% in comparison to the 20-day moving average, which settled at $67.45. In addition, CVS Health Corp saw 54.85% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Clark James David, who sale 7,513 shares at the price of $66.35 back on Mar 05 ’25. After this action, Clark James David now owns 8,394 shares of CVS Health Corp, valued at $498,488 using the latest closing price.
Clark James David, the Officer of CVS Health Corp, proposed sale 7,513 shares at $66.35 during a trade that took place back on Mar 05 ’25, which means that Clark James David is holding shares at $498,489 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.14 for the gross margin
The net margin for CVS Health Corp stands at 0.01. The total capital return value is set at 0.05. Equity return is now at value 6.07, with 1.78 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is 2.88.
Currently, EBITDA for the company is 13.7 billion with net debt to EBITDA at 5.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.43. The receivables turnover for the company is 10.22for trailing twelve months and the total asset turnover is 1.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
To sum up, CVS Health Corp (CVS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
